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ABSTRACT Telomere shortening and telomerase activa-
tion in human somatic cells have been implicated in cell
immortalization and cellular senescence. To further study the
role of telomerase in immortalization, we assayed telomere
length and telomerase activity in primary mouse fibroblasts,
in spontaneously immortalized cell clones, and in mouse
tissues. In the primary cell cultures, telomere length de-
creased with increased cell doublings and telomerase activity
was not detected. In contrast, in spontaneously immortalized
clones, telomeres were maintained at a stable length and
telomerase activity was present. To determine if telomere
shortening occurs in vivo, we assayed for telomerase and
telomere length in tissues from mice of different ages. Telo-
mere length was similar among different tissues within a
newborn mouse, whereas telomere length differed between
tissues in an adult mouse. These findings suggest that there is
tissue-specific regulation of mouse telomerase during devel-
opment and aging in vivo. In contrast to human tissues, most
mouse tissues had active telomerase. The presence of telom-
erase in these tissues may reflect the ease of immortalization
of primary mouse cells relative to human cells in culture.
Accurate chromosome transmission during cell division is
essential for cell survival. When chromosome integrity is lost,
cell death or unregulated growth may occur. Telomeres sta-
bilize natural chromosome ends and inhibit aberrant fusions
and rearrangements that occur on broken chromosomes. Telo-
mere sequences consist of short G-rich repeats that are highly
conserved in eukaryotes, although the exact repeat sequence
is species-specific (reviewed in ref. 1). Telomere repeats are
synthesized de novo onto chromosome ends by the enzyme
telomerase (2, 3). This addition compensates for the inability
of conventional DNA polymerases to completely replicate
DNA ends (refs. 4 and 5; reviewed in ref. 1). Telomerase is a
ribonucleoprotein enzyme; the essential RNA component
provides the template for telomere repeat synthesis. Telom-
erase activity has been isolated from the ciliates Tetrahymena,
Euplotes, and Oxytricha as well as from immortalized human
and mouse cells lines (2, 6-9).
Telomere length regulation in mammalian cells is complex.
Human sperm telomeres are longer than those in somatic cells
(10). Somatic cell telomeres shorten with each cell division in
vitro and telomere length correlates with the life-span of
fibroblasts in culture. Cells with longer telomeres undergo
more divisions than those with short telomeres (11-13). Telo-
mere shortening is also observed in vivo. In a variety of tissues
telomeres are shorter in older individuals than in younger
individuals (13-16).
Telomere length also differs between normal somatic cells
and cancer cells (14, 17, 18). The average telomere length in
colorectal carcinoma tissue and ovarian carcinoma is shorter
than that in the corresponding normal tissue from the same
individual (14, 18). To determine what occurs when telomeres
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from cancer cells become very short, telomere length and
telomerase activity were assayed in primary human cells
transfected with simian virus 40 large tumor (SV40 T) antigen
(19). The expression of SV40 T antigen in primary human cells
allows growth for an extended number of cell doublings, and
the culture enters "crisis" where most of the cells die; however,
at a low frequency, some cells will become immortalized (20).
During the extended life-span, telomeres shortened and te-
lomerase activity was not detected. After crisis, the cells that
survived had stabilized telomere length and telomerase activ-
ity was detected (19). This suggests that telomerase activity in
the immortal cells allows maintenance of telomere length.
Since telomeres are required for chromosomes stability, those
cells that express or reactivate telomerase may be selected for
at crisis. Thus telomerase activity may be required for the
growth of immortalized human cells (19).
To develop a mouse model to study telomere length and
telomerase we initially characterized mouse telomerase activ-
ity (9). Detection of changes in telomere length is difficult in
most inbred mouse strains because they have telomere restric-
tion fragment lengths of up to several hundred kilobase pairs
(21, 22). We therefore studied telomere length regulation in
vivo and in vitro in Mus spretus. We chose M. spretus because
its has telomere restriction fragment lengths similar to those of
humans (22) and are thus easily resolved in agarose gels. In
contrast to primary human cells, mouse cells will spontane-
ously immortalize in culture (23). Thus telomere length and
telomerase activity during immortalization can be assayed
without introduction of exogenous agents. In one mouse
primary culture where telomeres shortened, telomerase activ-
ity was not detectable. After an apparent crisis, and telomere
length stabilization, telomerase activity was detected. Al-
though two primary fibroblast cultures lacked detectable te-
lomerase, many mouse tissues had high levels of telomerase
activity. The presence of telomerase activity in normal mouse
cells may play a role in the ease of immortalization of these
cells in culture.
MATERIALS AND METHODS
Mice. BALB/c, W/WV, and breeding pairs of M. spretus
were obtained from The Jackson Laboratory. Familial samples
ofM spretus were obtained from Verne Chapman (Roswell
Park Cancer Institute, Buffalo, NY).
Primary Fibroblasts. Skin explants from newborn mice (1-2
mm2 pieces) were excised and placed dermis side down in a
25-cm2 T flask in 0.5 ml of Dulbecco's modified Eagle's
medium and 10% of fetal bovine serum (plus penicillin and
streptomycin). The explants were allowed to adhere for 15 min;
then the flask was inverted and 4.5 ml of medium was added
to the opposite face of the flask. The cells were grown inverted
overnight, the flask was then inverted, and the cultures were
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refed every third day. When fibroblasts had migrated to cover
the flask (typically at 10-14 days), the explant was removed
and the cells were trypsinized and counted. The initial popu-
lation doubling (PD) level was calculated by assuming an initial
outgrowth of 200 cells per explant (24). At each passage,
fibroblasts were plated at 5 X 105 cells per 10-cm dish in 8 ml
of medium, and the remaining cells were frozen in medium
plus 10% dimethyl sulfoxide. The cells were passaged every
3-4 days and the cell number and PD were determined for
each passage.
DNA Isolation. Genomic DNA was prepared from cultured
cells by standard protocols. Briefly, cells were washed in
phosphate buffered saline (PBS), resuspended in TE at 5 x 107
cells per ml, and added to 10 vol of a buffer containing 10 mM
Tris, 100 mM EDTA (pH 8), 100 M NaCl, 0.5% SDS, and 100
gg of proteinase K per ml. The mixture was incubated at least
3 hr at 50°C and then cooled to 37°C and incubated with 100
,ug of DNase-free RNase per ml for 1 hr. The samples were
extracted with phenol and precipitated with 0.2 M NaCl and
ethanol, and the DNAwas dissolved in TE. For tissue samples,
the tissues were placed in 10 ml of the above buffer per g of
tissue and Dounce homogenized to disrupt the tissue. The
extract was then placed at 50°C and treated as above.
Gel Hybridization and Terminal Restriction Fragment
(TRF) Length Analysis. Total genomic DNA was digested for
16 hr with Hinfl at 37°C. The DNAwas extracted with phenol,
precipitated with ethanol, and dissolved in TE, and equal
aliquots (2-p,g samples) were separated in 0.5% agarose gels.
The gels were dried for 1.5 hr at 60°C as described (25),
denatured for 30 min in 0.5 M NaOH/1.5 M NaCl, and
neutralized for 30 min in 0.5 M Tris, pH 7/1.5 M NaCl. After
rinsing briefly in water, the gels were hybridized for 16 hr in 0.5
M Na2HPO4/1 mM EDTA/7% SDS/1% bovine serum albu-
min at 37°C. The gels were washed with 2 liters of 0.5 x SSC
and 0.1% SDS at 37°C before autoradiography. To determine
TRF length, a Fuji BAS2000 PhosphorImager was used to
quantitate the radioactive signal in each of the lanes. Each lane
was graphically divided into quadrants and the amount of
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radioactivity in each was determined. The molecular weight
range of each quadrant was calculated by plotting the position
of the radioactive markers versus the logarithm of their
molecular weights. The mean length of the telomere restriction
fragments was then calculated as described (13).
Extracts and Telomerase Assays. S-100 extracts from FM3A
and cultured fibroblast cells were prepared as described (9, 19).
To prepare mouse tissue S-100 extracts, freshly dissected
tissues were rinsed in cold PBS, minced, and weighed. The
minced tissue was placed in 0.75 vol of cold "hypo" buffer per
g of tissue for 10 min on ice and disrupted by Dounce
homogenization. The homogenate was then treated as de-
scribed (9, 19). All S-100 extracts were fractionated on DEAE-
agarose columns and eluted with 0.2 M NaCl (9). For some
extracts, the 0.2 M DEAE fractions were then passed over a
phenyl Sepharose column. Conventional telomerase activity
was assayed as described (9). The PCR-based assay (TRAP
assay) was performed as described (26).
RESULTS
Telomeres Shorten During Growth of Mouse Fibroblasts in
Culture. Telomeres in primary human cells shorten with age in
vitro and in vivo (11, 13, 14, 16). To determine whether
telomere shortening occurs in mice, we assayed telomere
length in primary mouse fibroblast cultures. PrimaryM. spretus
fibroblasts were obtained from skin explants taken from
newborn mice using conditions similar to those for culturing
human skin fibroblasts (see Materials and Methods). We began
with three independent skin explants from three newborn
mice, and all three sets led to actively growing cultures. The
fibroblast cultures were passaged every 3-4 days and the
growth kinetics (Fig. IB) and morphology of the cells were
monitored. Genomic DNA was isolated at regular intervals,
digested with Hinfl, and separated on a 0.5% agarose gel. To
avoid loss of high molecular weight DNA during Southern
transfer, the gel was dried and hybridized directly with the
telomeric d(TTAGGG)3 probe (Fig. 1A) (25). This probe
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FIG. 1. (A) Telomere shortening in cultured M. spretus fibroblasts. Telomere length was determined at different PD levels from M. spretus
fibroblast culture MSF1B. The asterisk marks the PD level where cell morphology changes were first evident. (B) Graph of the growth rate of three
different mouse fibroblast cultures. The estimated number of mean PDs (MDP) are plotted versus the number of days in culture. The arrowheads
mark the points at which telomerase was assayed.
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hybridizes to restriction fragments containing internal se-
quence repeats in the mouse genome as well as to the telomeric
fragments (27). The telomeric bands were identified by their
sensitivity to BAL-31 exonuclease digestion (data not shown).
We refer to the telomeric bands as TRFs because they
comprise telomere adjacent DNA sequence in addition to the
telomeric d(TTAGGG) repeats.
The TRF length decreased by 75 ± 9 bp per cell generation
in vitro up to 60 doublings in MSF1B (Fig. 1A). After PD 60
the TRF length stabilized and remained constant as the
population continued growing. Similar results were obtained
with the MSF1A cell culture (data not shown), although the
growth kinetics and time of immortalization and subsequent
TRF length stabilization differed between the two cultures.
We were not able to measure telomere length over time in the
third culture (MSF3) due to contamination in the culture. The
shortening and subsequent stabilization of telomere length in
MSF cells were similar to that seen pre- and postcrisis during
immortalization of human cells (19, 28, 29). In contrast to
human cells, the precise point of immortalization was difficult
to determine in the mouse cell cultures. In culture 1A the
growth rate of the culture slowed between PD 30 and PD 35;
however, in culture 1B there was little change in growth rate.
The cells in culture 1B initially had a uniform fibroblast
morphology; however, at PD 60 a morphological change was
apparent in some cells and by PD 65 the majority of the cells
were enlarged and non-uniform in size (data not shown).
Telomerase Activity Detected after Immortalization. We
assayed cell extracts from MSF1A and MSF1B for telomerase
activity at different PD levels using the conventional telomerase
assay (data not shown) and the PCR-based "TRAP" assay (26)
(Fig. 2). Telomerase was not detected early (PD 18) in MSF1B
when telomere lengths were shortening; at PD 52 some telom-
erase was detected, and activity was detected at the latest time
point, PD 80. Activity was also detected at late points in MSF1A
and at one early point in MSF3 (see below). Although the
conventional assay using mouse telomerase generates one pre-
dominant product (9), the TRAP assay results in a ladder of
products with a 6-base periodicity. The ladder is the result of
greater processivity of the mouse telomerase under the PCR
conditions as well as the length increase of the repeated se-
quences due to out-of-frame primer annealing during PCR (L.
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Mantell, KR.P., N. Kim, K Buchkovich, and C.W.G. unpub-
lished data). The lack of a distinct crisis in the mouse cultures
makes it difficult to pinpoint the exact point of immortalization.
However, the presence of telomerase in the late stage but not
earlyMSF1B culture, togetherwith the telomere length data (Fig.
1), suggest that telomerase-positive cells were selected for in the
growth of the culture.
Developmental and Tissue-Specific Telomere Length Reg-
ulation. To determine whether telomere shortening occurs in
mouse tissues in vivo, we examined telomere length in M.
spretus tissues at different ages (Fig. 3). As was found in
humans, TRF length in a given tissue differed between indi-
viduals of the same age. For example, the two newborns
examined in Fig. 3 are littermates, yet the mean size of the
tissue TRFs in Msl are longer by several kilobase pairs as
compared to the mean TRF lengths in Ms2. We attribute the
length differences to the outbred genetic background in these
wild-derived mice. We have analyzed liver TRF length in 12
different species ofMus musculus and 9 different wild-derived
species. The TRFs from all of the musculus strains were at limit
mobility (>30 kb), while the TRFs of all wild-derived species
were resolvable (<25 kb) (data not shown). This suggests that
the musculus species may have unusually long telomeres
among mice. Due to the degree of genetic variation in the
population, a large number of M. spretus at different ages will
be needed to obtain statistically significant data on telomere
length changes during aging.
Comparing the relative lengths ofTRFs between tissues within
individual mice, we found interesting differences. Telomere
lengths within the tissues analyzed of any individual newborn
mouse were similar, while those within any individual adult
mouse (2 months or older) differed between tissues (Fig. 3). The
most striking difference lies in the length of the major telomeric
band in the testis sample relative to the kidney and brain samples
of the same adult mouse. The meanTRF length of the adult testis
was quantitated using a PhosphoImager; it was consistently 2-3
kbp longer relative to the kidney and brain TRFs. In addition to
longer testis telomeres, telomere length in liver was also 1 kbp
longer than the kidney and brain telomeres. This difference in
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FIG. 2. Telomerase activity detected at late PDs in M. spretus
fibroblasts. Telomerase activity was assayed using the TRAP assay.
Lane 1, MSF1B cells at PD 18 (early); lane 2, MSF1B at PD 52 (mid);
lane 5, MSF1B cells at PD 80 (late); lane 3, MSF3 cells (early) (PD 20);
lane 4, MSF1A cells at PD 70 (late). Lanes 6-13, controls for the PCR.
Lane 6, 293 cell extract (positive control); lane 7, RNase-treated 293
cell extract; lanes 8 and 9, no extract controls; lanes 10-13, 5-fold serial
dilutions of the 293 cell extract.
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FIG. 3. Tissue telomere lengths change with age. Genomic DNA
was isolated from individual male M. spretus (Ms) tissues and analyzed
as in Fig. 1. Msl-Ms6 are offspring of Ms7. Msl and Ms2, newborn
littermates; Ms3 and Ms4, 2-month littermates; Ms5 and Ms6, 4-month
littermates; Ms7, 9-month parent. L, liver; B, brain; K, kidney; T, testis.
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tissue TRF length within an individual mouse was apparent by 2
months of age and was manifested in all adults up to 9 months,
the oldest mouse examined.
Telomerase Activity in Mouse Tissues. The difference in
telomere length between tissues of the same adult mouse can
be interpreted in several ways. The telomeres in newborn
mouse tissues could shorten during postnatal development
only in specific tissues while shortening might not occur in
other tissues. Alternatively, telomeres in some tissues could
become longer during development. Finally, a combination of
both processes could be occurring. To determine whether
telomerase is active in specific mouse tissues, we assayed
extracts from adult mouse brain, liver, kidney, spleen, and
testis. No activity was detected in brain. However, readily
detectable telomerase activity was observed in extracts from
testis and liver, and weaker activity was also detected in kidney
and spleen extracts (Fig. 4 and data not shown). The presence
or absence of telomerase in these tissue extracts was confirmed
using the TRAP assay (Fig. 4B) (26). Under the conditions of
this PCR-based assay, quantitative differences between tissues
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cannot be determined, although the qualitative differences
such as the presence or absence of a signal are meaningful (N.
Kim, K. Buchkovich, L. Mantell, and C.W.G., unpublished
data). Telomerase was detected in testes, liver, and kidney
from C57BL/6 and BALB/c mice and in the spleen from
BALB/c mice (data not shown). Initially all of the telomerase
assays were done in these strains ofM musculus; however, to
confirm these results in a second species, we also assayed
tissues fromM spretus. Activity was present in both testes and
in liver fromM spretus (Fig. 4B). The presence of detectable
telomerase activity in these two tissues correlates with the
longer telomere lengths observed in testes and liver in adult
mice and suggests an active mechanism for maintaining long
telomeres in these tissues.
To explore the temporal regulation of telomere length
changes in testis and liver, telomerase activity was assayed in
these tissues at different developmental stages inM musculus.
Activity was detected in liver at the earliest point tested (4
weeks) and was present at all subsequent ages tested (data not
shown). However, in the testis, telomerase activity was not
detected at 4 weeks but was detected at 6 weeks of age and
older (Fig. 5). Although a direct comparison cannot be made
because the telomere length and telomerase activity were from
two different mouse species, it was interesting that the devel-
opmental stage at which telomere lengthening was observed is
similar to the stage where telomerase was first detected. The
first mature sperm are produced about 5-6 weeks after birth,
and after 6 weeks of age spermatocytes constitute a significant
proportion of the mass of the testis. The longer TRF length and
detectable telomerase activity may reflect this increased mass
of spermatocytes in the testis after 6 weeks.
To determine whether testis telomerase activity was due to
developing sperm or to another cell type within the testis, we
utilized a mutant strain of M musculus (W/WV) that lack
primary spermatogonia but otherwise have a structurally
normal testis (30). The W/WV mutation causes sterility in
homozygotes by reducing the proliferation of the primordial
germ cells and their migration into the genital ridge during
development. Heterozygotes have normal germ cell prolifer-
ation and migration. Mutant (homozygotes) and normal (het-
erozygotes) mouse testes were assayed for telomerase activity.
No activity was detected in 8-week-old mutant W/Wv testis,
whereas in siblings that contain normal testes, telomerase
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FIG. 4. Telomerase activity in mouse tissues. (A) The brain and
spleen S-100 extracts were prepared from a pool of four BALB/c mice
(7 months); the liver and testis S-100 extracts were obtained from
individual BALB/c mice (4 months and 3 months, respectively). All
S-100 extracts were fractionated over DEAE-agarose columns. The
spleen and testis DEAE fractions were subjected to further fraction-
ation over phenyl Sepharose. An aliquot (40 ,ul) of each sample was
treated with (+) or without (-) RNase and then assayed for telom-
erase activity using the conventional telomerase assay. Lanes 1 and 2,
FM3A DEAE; lanes 3 and 4, brain; lanes 5 and 6, liver; lanes 7 and 8,
testis; lanes 9 and 10, spleen. (B) Telomerase activity assayed by the
TRAP assay. M and S refer to extracts made from M. musculus (M)
(pooled tissues from 6 animals) or tissue from a single M. spretus (S).
Lane 1, FM3A DEAE; lanes 2 and 3, kidney; lanes 4 and 5, brain; lanes
6 and 7, liver; lanes 8 and 9, testes; lanes 10 and 11, spleen DEAE
fraction (0.2 and 0.3 M NaCl eluates).
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FIG. 5. Testis telomerase activity is developmentally regulated.
Testis telomerase activity in mice of different ages. Testis S-100
extracts were prepared from pools of four BALB/c mice from each of
the indicated ages and were fractionated over DEAE-agarose and
phenyl Sepharose columns. An aliquot (40 ,ul) of each sample was
treated with (+) or without (-) RNase and then assayed for telom-
erase activity. Lanes 1 and 2, FM3A; lanes 3-16, testis at 2 weeks (lanes
3 and 4), 4 weeks (lanes 5 and 6), 6 weeks (lanes 7 and 8), 8 weeks (lanes
9 and 10), 10 weeks (lanes 11 and 12), 13 weeks (lanes 13 and 14), and
16 weeks (lanes 15 and 16).
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activity was detected (data not shown). This suggests that the
telomerase activity originates from the progenitor sperm cells
and not another cell type within the testis.
DISCUSSION
Telomerase in Mouse Tissues. Studies on human telomere
length and telomerase activity have suggested that telomerase
activity may be restricted to germ-line cells and cancer tissue.
We have used the mouse as a model to study the regulation of
telomerase in mammalian development. We were surprised to
find that many somatic mouse tissues, unlike human tissues,
have significant telomerase activity. The telomerase activity
detected in mouse tissues may be due to telomerase expression
in all cells or expression in a limited subset of cells, such as stem
cells. Our current assays are not able to distinguish telomerase-
positive and -negative cells at the individual cell level.
Our data suggest that tissue specific developmental regula-
tion of telomere length may occur in mice. Telomere lengths
between tissues in any individual newborn mouse were similar
while those in any individual adult mouse differed in size. Long
telomere lengths and telomerase activity were detected in the
testis about 5-6 weeks after birth. At this time, the testis
increases dramatically in size due to the production of the first
spermatocytes. Thus the shorter relative TRF length and lack
of detectable telomerase activity in immature mouse testis may
reflect the relatively low mass of germ cells. The lack of
telomerase activity in mature W/Wv mutant mice that lack
germ cells indicates that the testis telomerase activity is present
in the germ line and not the somatic cells of the testis.
Telomerase in Primary and Spontaneously Immortalized
Mouse Fibroblasts. Two cultures of M. spretus fibroblasts
showed initial telomere shortening and undetectable telom-
erase followed by telomere length stabilization and detectable
telomerase activity. In the MSF1A culture, the detection of
telomerase correlated with an improvement in the growth rate
of the culture. This growth rate improvement is often referred
to as the point of immortalization of fibroblast cultures (23).
In the MSF1B culture there was no change in the growth rate;
however, a morphological change in the cells was noted
between PD 60 and PD 65. In a third culture, MSF3, telom-
erase was detected at early passage. The population of cells
that first grow out of the skin explant may determine whether
telomerase is present or absent at early passage levels. The
detection of telomerase late in culture growth could result
from an activation of telomerase in a subpopulation of cells or
the selection for cells in the population that initially expressed
telomerase.
M. spretus cells, like many rodent cells, will spontaneously
immortalize in culture, although at a lower frequency than M.
musculus cells (A. Balmain, personal communication). We
established two fibroblast cultures from M. spretus that lacked
detectable telomerase and one culture that had detectable
telomerase. Primary mouse embryo fibroblasts from M. mus-
culus have detectable telomerase activity at very early passage
(K. Buchkovich and C.W.G., unpublished data). The differ-
ence between these cells and the M. spretus fibroblasts de-
scribed here may be due to the tissue origin (fetal versus
newborn or mixed origin versus skin fibroblasts) or a species-
specific difference between musculus and spretus.
Telomerase Expression in Human Versus Mouse Tissues.
Although telomere shortening and subsequent stabilization in
primaryM spretus fibroblasts is similar to that found in human
cells, the presence of telomerase activity in many mouse tissues
is very different (26). No detectable telomerase activity was
found using the sensitive TRAP assay in >50 samples of
human tissue including human liver samples (ref. 26; J. Shay,
personal communication). One explanation for this difference
could be that mouse cells lack a telomerase regulatory pathway
that is present in human cells. Primary human cells rarely, if
ever, spontaneously immortalize, while mouse cells can spon-
taneously immortalize. If, for example, human cells have two
separate pathways that regulate telomerase and mouse cells
have only one of these pathways, it will take fewer "hits" to
inactivate the one mouse regulatory pathway versus the two for
human.
The regulation of proliferation is thought to play a role in the
protection against carcinogenesis. The requirement for mul-
tiple hits for cancer development is reflected in the increased
cancer incidence with increased age. Long-lived species there-
fore may have more control mechanisms to limit cellular
proliferation than short-lived species. The inhibition of telom-
erase activity may be one mechanism used by humans, a
long-lived species, to limit replicative potential. Further studies
of mouse telomerase should provide a model to explore the
role of telomere length and telomerase in cellular senescence
and immortalization.
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